| Ditemukan 1321 dokumen dengan kata kunci 4042 |
Simpan CSV  |
|
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|
|
|
|
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
|
|
|
|
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.9, 1 May, 2013: p.595-605 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer
|
|
|
|
Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy
|
|
|
|
Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis
|
|
|
|
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensivedisease- small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
|
|
|
|
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
|
|
|
|
Generation of human endometrial knockout cell lines with the CRISPR/ Cas9 system confirms the prostaglandin F2a synthase activity of aldoketoreductase 1B1
|
| No. Panggil: MHR Basic science of reproductive medicine; Volume 20, No.7, July 2014: p.650–663 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
|
|
|
Hasil Pencarian
